{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:28:58Z","timestamp":1717115338147},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,30]]},"DOI":"10.7759\/cureus.61368","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T14:40:42Z","timestamp":1717080042000},"source":"Crossref","is-referenced-by-count":0,"title":["\"The Failing Watchman\": Recurrent Left Atrial Appendage Occlusion Device (LAAOD) Thrombus After Successful Initial Implantation"],"prefix":"10.7759","author":[{"given":"Omar","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Egbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danish","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear JL","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996, 61:755-9. 10.1016\/0003-4975(95)00887-X","journal-title":"Ann Thorac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy VY","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, et al.. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014, 312:1988-98. 10.1001\/jama.2014.15192","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes DR Jr","year":"2014","unstructured":"Holmes DR Jr, Kar S, Price MJ, et al.. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014, 64:1-12. 10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al.. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017, 70:2964-75. 10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy VY","year":"2011","unstructured":"Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011, 123:417-24. 10.1161\/CIRCULATIONAHA.110.976449","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet","volume":"90","author":"Lempereur M","year":"2017","unstructured":"Lempereur M, Aminian A, Freixa X, et al.. Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv. 2017, 90:E111-21. 10.1002\/ccd.26903","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.05.006","article-title":"Incidence, characteristics, and clinical course of device-related thrombus after\u00a0Watchman left atrial appendage occlusion device implantation in atrial fibrillation patients","volume":"3","author":"Kubo S","year":"2017","unstructured":"Kubo S, Mizutani Y, Meemook K, Nakajima Y, Hussaini A, Kar S. Incidence, characteristics, and clinical course of device-related thrombus after\u00a0Watchman left atrial appendage occlusion device implantation in atrial fibrillation patients. JACC Clin Electrophysiol. 2017, 3:1380-6. 10.1016\/j.jacep.2017.05.006","journal-title":"JACC Clin Electrophysiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008693","article-title":"WATCHMAN device-related thrombus successfully treated with apixaban: a case report","volume":"96","author":"Wong CK","year":"2017","unstructured":"Wong CK, Chan PH, Lam CC, Kwok OH, Lam YY, Siu CW. WATCHMAN device-related thrombus successfully treated with apixaban: a case report. Medicine (Baltimore). 2017, 96:e8693. 10.1097\/MD.0000000000008693","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25456","article-title":"Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device)","volume":"85","author":"Lam SC","year":"2015","unstructured":"Lam SC, Bertog S, Sievert H. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device). Catheter Cardiovasc Interv. 2015, 85:321-7. 10.1002\/ccd.25456","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.12.017","article-title":"Multiple thromboembolic events from a left atrial appendage occlusion device","volume":"34","author":"Prosperi-Porta G","year":"2018","unstructured":"Prosperi-Porta G, Schnell G, Colbert J, Franko A, Wilton SB, Kuriachan VP. Multiple thromboembolic events from a left atrial appendage occlusion device. Can J Cardiol. 2018, 34:342.e13-5. 10.1016\/j.cjca.2017.12.017","journal-title":"Can J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246736-the-failing-watchman-recurrent-left-atrial-appendage-occlusion-device-laaod-thrombus-after-successful-initial-implantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T14:40:46Z","timestamp":1717080046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246736-the-failing-watchman-recurrent-left-atrial-appendage-occlusion-device-laaod-thrombus-after-successful-initial-implantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.61368","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}